Meeting
2019 Gastrointestinal Cancers Symposium
Baseline and longitudinal quantification of lean muscle mass using routine CT measurements prior to resection for pancreatic adenocarcinoma.
Authors
Paul Eliezer Oberstein
New York University Perlmutter Cancer Center, New York, NY
Paul Eliezer Oberstein , Vilma Rosario , Xiaotao Guo , Binsheng Zhao , Jeanine M Genkinger , Michael D. Kluger , John A. Chabot
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 198)
DOI
10.1200/JCO.2019.37.4_suppl.198
Abstract #
198
Poster Bd #
A14
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Body composition measurements and overall survival in patients with resectable pancreatic adenocarcinoma receiving neoadjuvant chemotherapy: Analysis from SWOG S1505.
First Author: Davendra Sohal
Poster
2018 ASCO Annual Meeting
Management and outcome of patients with neo-adjuvant chemotherapy (CT) in locally advanced soft-tissue sarcoma (LASTS): The Gustave Roussy experience.
First Author: Sarah Naomie Dumont
Poster
2024 ASCO Annual Meeting
Short-course radiotherapy (SCRT) followed by fruquintinib plus adebrelimab and CAPOX in the total neoadjuvant therapy of locally advanced rectal cancer (LARC): A multicenter, single-arm, open-label, phase II study.
First Author: Zhenyu Lin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Non-responders to neoadjuvant chemotherapy in pancreatic adenocarcinoma: Characteristics and outcomes.
First Author: Brendan Hagerty